Pulse Oximeters Market Size To Hit USD 5.13 Bn By 2032

The pulse oximeters market size was valued at USD 2.1 billion in 2022 and is expected to reach USD 5.13 billion by 2032, growing at a CAGR of 9.40% from 2023 to 2032.

Table of Contents

Key Takeaways

North America has held the maximum revenue share in 2022.
By Product Type, the handheld oximeters segment has held the largest revenue share in 2022.
By End-Use, the hospitals segment had the major market in 2022.
By End-Use, the home healthcare segment is expected to expand at the fastest CAGR over the projected period.

The pulse oximeter market is anticipated to witness robust growth during the forecast period. The pulse oximeter market is primarily driven by the increasing prevalence of chronic obstructive pulmonary disease, respiratory diseases such as asthma. Moreover, the growing demand for portable and remote patient monitoring devices is resulting in augmented demand for pulse oximeters. Furthermore, rising awareness regarding noninvasive devices coupled with the widespread adoption of healthcare devices by population is projected to drive the growth of the pulse oximeter market. On the other hand, the high cost and low penetration of medical devices in developing economies are restraining the growth of the pulse oximeter market during the forecast period. However, the technological advancements in medical devices are anticipated to present lucrative opportunities in the market over the projection period.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1036

Pulse Oximeters Market Scope

Report Coverage	Details
Growth Rate from 2023 to 2032	CAGR of 9.40%
Market Size in 2023	USD 2.28 Billion
Market Size by 2032	USD 5.13 Billion
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Product, End Users
Regional Scope	APAC, North America, Latin America, Europe, MEAN

Escalating implementation of wireless pulse oximeters by home consumers and clinicians is projected to spur the sale of pulse oximeters worldwide. Portability offered by wireless pulse oximeters is propelling growth of finger-top and wrist pulse oximeters, specifically in home care situations. Masimo introduced wireless pulse oximeter named, Masimo Rad – 5, that achieved enormous popularity due to its superior wireless features.

Why Pulse Oximeter?

A pulse oximeter is an electronic device that is extensively used to monitor the amount of oxygen in the blood as well as to track the pulse rate. Furthermore, undiagnosed or untreated hypoxemia may lead to shortness of breath, rapid breathing, dizziness, lack of coordination, and visual disorders. A pulse oximeter provides numerous assistances like valuable acumens regarding oxygen saturation percentage, notifying inferior oxygen levels on anesthesia state, and surveillance of breathing motion of neonates under particular drugs.

In addition, the pulse oximeter has the ability to act as a diagnostic device in respiratory and cardiac diseases. Moreover, the simplicity of usage and ability to deliver constant and instant oxygen saturation values has made pulse oximeters of acute prominence in emergency medical care or first aid. Pulse oximeters are beneficial for patients with a cardiac problem, respiratory problems, and chronic obstructive pulmonary diseases.

Report Highlights

Demand for fingertip pulse oximeters has perceived a substantial spike during the first quarter of 2020 owed to proliferating COVID-19 pandemic
Handheld pulse oximeters are projected to be in high demand during the COVID-19 epidemic, as these devices are more accurate and come with probes that can be used for individual patients to limit the spread of the virus
There is mounting inclination in the practice of oxygen saturation monitors in home healthcare settings because of the enlargement of the homecare sector. Hospitals and nursing care centers are obtaining the medical device to take better care to their patients.
The pulse oximeters industry is also witnessing mergers, acquisitions, and licensing agreements.
Pulse oximeters market is budding substantially with the intensifying application of wearable devices and mobile-based platforms to establish the level of oxygen saturation in the patients.

Regional Snapshots

Worldwide, North America conquered the pulse oximeter market with majority revenue share due to augmented elderly population, improved healthcare system, and the existence of lively American Academy of Pediatrics, which approves the product in a great way. All this together will boost substantial growth in the global pulse oximeters market. Furthermore, the higher adoption of these devices and greater consciousness amid patients and wardens are accountable for the uppermarket share of the North America region in the pulse oximeters sector. However, the Asia Pacific region is anticipated to witness significant growth during the forecast period. Oxygen saturation monitors are essential section of the regular patient observation procedures in clinics and hospitals in nations such as New Zealand and Australia.

Key Players & Strategies

Omron Healthcare, Inc. is one of the major players in the global pulse oximeters market. Omron Healthcare, Inc. is estimated to retain its position in the forecast duration because of its diverse product portfolio and efficient customer reach. Additionally, strong research and development division of Omron Healthcare, Inc. is assisting the company to innovate new concepts and to design products with supreme efficiency.These vendors are adopting various key business strategies such as product launches, mergers & acquisitions, and partnerships & collaborations to expand market share and gain a competitive advantage.

Some of the significant players in the pulse oximeters market include:

Smiths Group plc.
Halmaplc
Koninklijke Philips N.V.
Medtronic plc
Nihon Kohden Corporation
Masimo Corporation
Contec Medical Systems Co., Ltd.
Omron healthcare, Inc.
General Electric Company
Nonin Medical, Inc.

Segments Covered in the Report

By Product Type

Handheld Oximeters
Fingertip Oximeters
TabletopOximeters

By End-user

Ambulatory Surgical Centers
Hospitals
Home Healthcares

By Regional Outlook

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- South Korea
Rest of the World

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Pulse Oximeters Market, By Product

7.1. Pulse Oximeters Market, by Product Type, 2023-2032
7.1.1. Handheld Oximeters
7.1.1.1. Market Revenue and Forecast (2020-2032)
7.1.2. Fingertip Oximeters
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Tabletop Oximeters
7.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 8. Global Pulse Oximeters Market, By End-user

8.1. Pulse Oximeters Market, by End-user, 2023-2032
8.1.1. Ambulatory Surgical Centers
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Home Healthcares
8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Pulse Oximeters Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.2. Market Revenue and Forecast, by End-user (2020-2032)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.4.2. Market Revenue and Forecast, by End-user (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.2. Market Revenue and Forecast, by End-user (2020-2032)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.4.2. Market Revenue and Forecast, by End-user (2020-2032)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.5.2. Market Revenue and Forecast, by End-user (2020-2032)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.6.2. Market Revenue and Forecast, by End-user (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.4.2. Market Revenue and Forecast, by End-user (2020-2032)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.5.2. Market Revenue and Forecast, by End-user (2020-2032)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.6.2. Market Revenue and Forecast, by End-user (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.2. Market Revenue and Forecast, by End-user (2020-2032)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.4.2. Market Revenue and Forecast, by End-user (2020-2032)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.5.2. Market Revenue and Forecast, by End-user (2020-2032)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.6.2. Market Revenue and Forecast, by End-user (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.2. Market Revenue and Forecast, by End-user (2020-2032)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.3.2. Market Revenue and Forecast, by End-user (2020-2032)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.4.2. Market Revenue and Forecast, by End-user (2020-2032)

Chapter 10. Company Profiles

10.1. Smiths Group plc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Halmaplc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Koninklijke Philips N.V.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Medtronic plc
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Nihon Kohden Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Masimo Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Contec Medical Systems Co., Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Omron healthcare, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. General Electric Company
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Nonin Medical, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives